PRDM2 Antikörper (AA 1-347)

Produktnummer ABIN533010

Produktdetails anti-PRDM2 Antikörper

Target: PRDM2 (PR Domain Containing 2, with ZNF Domain (PRDM2))

Bindungsspezifität: AA 1-347

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser PRDM2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunoprecipitation (IP)

Verwendungszweck: Mouse monoclonal antibody raised against partial recombinant PRDM2.

Kreuzreaktivität: Human, Maus

Aufreinigung: Purified

Immunogen: Recombinant GST fusion protein corresponding to amino acids 1-347 of human PRDM2.

Klon: 33AT1045

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Western Blot (1:1000)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS (0.09 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-PRDM2 Antikörper (ABIN533010)

Cheng, Gao, Lou: "DNA methylation of the RIZ1 tumor suppressor gene plays an important role in the tumorigenesis of cervical cancer." in: European journal of medical research, Vol. 15, Issue 1, pp. 20-4, (2010) (PubMed).

Harsløf, Husted, Carstens, Stenkjaer, Langdahl: "Genotypes and haplotypes of the estrogen receptor genes, but not the retinoblastoma-interacting zinc finger protein 1 gene, are associated with osteoporosis." in: Calcified tissue international, Vol. 87, Issue 1, pp. 25-35, (2010) (PubMed).

de Vogel, Wouters, Gottschalk, van Schooten, de Goeij, de Bruïne, Goldbohm, van den Brandt, Weijenberg, van Engeland: "Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer." in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 18, Issue 11, pp. 3086-96, (2009) (PubMed).

Details zu PRDM2

Target: PRDM2 (PR Domain Containing 2, with ZNF Domain (PRDM2))

Andere Bezeichnung: PRDM2 (PRDM2 Produkte)

Synonyme: MGC114763 antikoerper, prdm2 antikoerper, riz antikoerper, kmt8 antikoerper, riz1 antikoerper, riz2 antikoerper, mtb-zf antikoerper, humhoxy1 antikoerper, PRDM2 antikoerper, HUMHOXY1 antikoerper, KMT8 antikoerper, MTB-ZF antikoerper, RIZ antikoerper, RIZ1 antikoerper, RIZ2 antikoerper, 4833427P12Rik antikoerper, E330024L24Rik antikoerper, Gm1033 antikoerper, Gm19732 antikoerper, Riz antikoerper, Riz1 antikoerper, Znfpr1c1 antikoerper, PR domain containing 2, with ZNF domain S homeolog antikoerper, PR domain containing 2, with ZNF domain b antikoerper, PR domain containing 2, with ZNF domain antikoerper, PR domain zinc finger protein 2 antikoerper, PR/SET domain 2 antikoerper, prdm2.S antikoerper, prdm2b antikoerper, prdm2 antikoerper, LOC100350859 antikoerper, PRDM2 antikoerper, Prdm2 antikoerper

Gen-ID: 7799

NCBI Accession: NM_012231, NM_01586